The molecular analysis technology developer, which counts Illumina among its investor base, has now raised almost $400m since it was founded in 2005.

The financial services group has brought together Fidelity Growth Partners Europe, Fidelity Growth Partners Asia and Moonray Investors into a single entity and armed it with $233m.

Karolinska Development loses half of its portfolio value as early-stage biotech investments value re-evaluated.

The venture capital fund has enlisted Airbus, Thales, Telespazio, Com Dev and Avanti for a fund that will target companies working on space technology.

Busuu has received $6.5m from McGraw-Hill Education and will incorporate the larger company's technology into its language learning platform.

Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.